Advancements in Cell and Gene Therapy: 2019 Year-in-Review

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Quality Starting Material: The Driving Force Behind Life-Saving Cell Therapies

By Jamie Margolis, PhD, SVP of Donor Services, NMDP/Be The Match®

Cell collection standards for cell therapies

A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies

How to overcome 3 common cell therapy supply chain disruptions

Design a tailored logistics plan to deliver

Overcoming challenges to cellular starting material collection

Q&A with the Be The Match BioTherapies Collection Network Liaison team

Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor

The benefits of a Quality System Audit Program

Accelerate patient access to cell and gene therapies

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization